The metabolic fate of tritiated methotrexate. II. Absorption and excretion in man.

Suppr

超能文献

作者信息

Henderson E S, Adamson R H, Oliverio V T

出版信息

Cancer Res. 1965 Aug;25(7):1018-24.

PMID:4284746

Abstract

摘要

相似文献

The metabolic fate of tritiated methotrexate. II. Absorption and excretion in man.

Cancer Res. 1965 Aug;25(7):1018-24.

How to use cancer chemotherapy.如何使用癌症化疗。

Am Fam Physician. 1971 Jun;3(6):73-84.

Prolonged intravenous methotrexate therapy in the treatment of acute leukemia and solid tumors.

Cancer Res. 1970 Aug;30(8):2132-8.

[On the value of chloroquine in the treatment of malignant tumor diseases].

Arch Geschwulstforsch. 1967;29(3):266-73.

[A new combination of methotrexate and folinic acid for cancer treatment (acute leukemia and solid tumors)].一种用于癌症治疗（急性白血病和实体瘤）的甲氨蝶呤与亚叶酸的新联合用药方案

Presse Med (1893). 1969 Mar 1;77(11):385-8.

[Preliminary results of clinical trial of the antineoplastic antibiotic bruneomycin].[抗肿瘤抗生素布鲁诺霉素的临床试验初步结果]

Antibiotiki. 1967 Jul;12(7):609-19.

The metabolic fate of tritiated methotrexate. I. Absorption, excretion, and distribution in mice, rats, dogs and monkeys.

Cancer Res. 1965 Aug;25(7):1008-17.

[Results of cooperative clinical study of the new antineoplastic antibiotic, bruneomycin].[新型抗肿瘤抗生素布鲁诺霉素的合作临床研究结果]

Antibiotiki. 1968 Sep;13(9):771-80.

Chemotherapy of neoplasia (cancer) with dehydroemetine.

J Trop Med Hyg. 1969 Dec;72(12):287-90.

[Loco-regional and sequential chemotherapy of advanced cancer].[晚期癌症的局部区域及序贯化疗]

Bull Mem Soc Med Hop Paris. 1968;119(10):847-55.

引用本文的文献

Extracorporeal Treatment for Methotrexate Poisoning: Systematic Review and Recommendations from the EXTRIP Workgroup.体外治疗甲氨蝶呤中毒：EXTRIP 工作组的系统评价和建议。

Clin J Am Soc Nephrol. 2022 Apr;17(4):602-622. doi: 10.2215/CJN.08030621. Epub 2022 Mar 2.

The chemotherapeutic drug methotrexate selects for antibiotic resistance.化疗药物甲氨蝶呤选择出抗生素耐药性。

EBioMedicine. 2021 Dec;74:103742. doi: 10.1016/j.ebiom.2021.103742. Epub 2021 Dec 11.

Perspectives of Methotrexate-Based Radioagents for Application in Nuclear Medicine.甲氨蝶呤基放射性药物在核医学中的应用展望。

Mol Pharm. 2021 Jan 4;18(1):33-43. doi: 10.1021/acs.molpharmaceut.0c00740. Epub 2020 Nov 30.

Severe bone marrow suppression due to methotrexate toxicity following aceclofenac-induced acute kidney injury.双氯芬酸诱导的急性肾损伤后，甲氨蝶呤毒性导致严重骨髓抑制。

BMJ Case Rep. 2018 Jun 5;2018:bcr-2018-224722. doi: 10.1136/bcr-2018-224722.

Involvement of Multiple Transporters-mediated Transports in Mizoribine and Methotrexate Pharmacokinetics.多种转运体介导的转运在米佐布宁和甲氨蝶呤药代动力学中的作用。

Pharmaceuticals (Basel). 2012 Aug 10;5(8):802-36. doi: 10.3390/ph5080802.

Pharmacokinetic considerations in clinical toxicology: clinical applications.临床毒理学中的药代动力学考量：临床应用

Clin Pharmacokinet. 2007;46(11):897-939. doi: 10.2165/00003088-200746110-00001.

Drug dosage in the elderly: dermatological drugs.老年人的药物剂量：皮肤科药物

Drugs Aging. 2006;23(3):203-15. doi: 10.2165/00002512-200623030-00003.

Mass balance studies, with a focus on anticancer drugs.以抗癌药物为重点的质量平衡研究。

Clin Pharmacokinet. 2006;45(1):33-58. doi: 10.2165/00003088-200645010-00003.

Pharmacokinetics and pharmacodynamics of methotrexate in non-neoplastic diseases.甲氨蝶呤在非肿瘤性疾病中的药代动力学和药效学

Clin Pharmacokinet. 2003;42(2):139-51. doi: 10.2165/00003088-200342020-00003.

Will pharmacogenetics allow better prediction of methotrexate toxicity and efficacy in patients with rheumatoid arthritis?药物遗传学能否更好地预测类风湿性关节炎患者甲氨蝶呤的毒性和疗效？

Ann Rheum Dis. 2003 Jan;62(1):4-9. doi: 10.1136/ard.62.1.4.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验